# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193805-23-000500
Filing Date
2023-04-05
Accepted
2023-04-05 06:45:38
Documents
45
Period of Report
2023-04-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | e618467_8k-immunic.htm iXBRL | 8-K | 19629
2 | PRESS RELEASE, DATED APRIL 5, 2023 | e618467_ex99-1.htm | EX-99.1 | 30639
3 | PRESENTATION, DATED APRIL 5, 2023 | e618467_ex99-2.htm | EX-99.2 | 21941
7 | GRAPHIC | image_002.jpg | GRAPHIC | 4012
8 | GRAPHIC | image_003.jpg | GRAPHIC | 4012
9 | GRAPHIC | slide1.jpg | GRAPHIC | 289852
10 | GRAPHIC | slide2.jpg | GRAPHIC | 340949
11 | GRAPHIC | slide3.jpg | GRAPHIC | 55193
12 | GRAPHIC | slide4.jpg | GRAPHIC | 119142
13 | GRAPHIC | slide5.jpg | GRAPHIC | 151595
14 | GRAPHIC | slide6.jpg | GRAPHIC | 174773
15 | GRAPHIC | slide7.jpg | GRAPHIC | 151498
16 | GRAPHIC | slide8.jpg | GRAPHIC | 167645
17 | GRAPHIC | slide9.jpg | GRAPHIC | 148767
18 | GRAPHIC | slide10.jpg | GRAPHIC | 146065
19 | GRAPHIC | slide11.jpg | GRAPHIC | 134768
20 | GRAPHIC | slide12.jpg | GRAPHIC | 169454
21 | GRAPHIC | slide13.jpg | GRAPHIC | 230659
22 | GRAPHIC | slide14.jpg | GRAPHIC | 164472
23 | GRAPHIC | slide15.jpg | GRAPHIC | 148469
24 | GRAPHIC | slide16.jpg | GRAPHIC | 116024
25 | GRAPHIC | slide17.jpg | GRAPHIC | 168399
26 | GRAPHIC | slide18.jpg | GRAPHIC | 191282
27 | GRAPHIC | slide19.jpg | GRAPHIC | 43133
28 | GRAPHIC | slide20.jpg | GRAPHIC | 145721
29 | GRAPHIC | slide21.jpg | GRAPHIC | 163153
30 | GRAPHIC | slide22.jpg | GRAPHIC | 34422
31 | GRAPHIC | slide23.jpg | GRAPHIC | 119592
32 | GRAPHIC | slide24.jpg | GRAPHIC | 48352
33 | GRAPHIC | slide25.jpg | GRAPHIC | 169941
34 | GRAPHIC | slide26.jpg | GRAPHIC | 201573
35 | GRAPHIC | slide27.jpg | GRAPHIC | 108379
36 | GRAPHIC | slide28.jpg | GRAPHIC | 152326
37 | GRAPHIC | slide29.jpg | GRAPHIC | 180527
| Complete submission text file | 0001193805-23-000500.txt |  | 6379433

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | imux-20230405.xsd | EX-101.SCH | 2947
5 | XBRL LABEL FILE | imux-20230405_lab.xml | EX-101.LAB | 34240
6 | XBRL PRESENTATION FILE | imux-20230405_pre.xml | EX-101.PRE | 22351
39 | EXTRACTED XBRL INSTANCE DOCUMENT | e618467_8k-immunic_htm.xml | XML | 3701

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 23801119
SIC: 2834 Pharmaceutical Preparations